Background: Dementia is a syndrome characterized by a decline in cognitive function, with Alzheimer's disease (AD) being the most common type. Updated global statistics on the burden of AD and other dementias provide critical insights for guiding prevention and treatment strategies. Objective: To estimate the global, regional, and national burden and attributable risk factors of AD and other dementias from 1990 to 2021. Methods: This cross-sectional study utilized the 2021 Global Burden of Disease (GBD) dataset from 204 countries and territories. The analysis focused on individuals aged 40 years and older with AD and other dementias and included data on incidence, all-cause and cause-specific mortality, disability-adjusted life years (DALYs), and estimated annual percentage changes (EAPCs). These trends were stratified by region, country, age, sex, and Socio-Demographic Index (SDI). Results: From 1990 to 2021, global DALYs attributable to AD and other dementias rose from 3.83 million to 9.84 million. Age-standardized rates (ASRs) of incidence and DALYs increased for both sexes, with a more pronounced rise in males. ASRs for incidence, prevalence, and DALYs were positively correlated with SDI. Smoking was identified as the primary risk factor for dementia burden among males, whereas obesity was the leading risk factor for females. Conclusions: The global burden of AD and other dementias has significantly increased from 1990 to 2021, especially in high-SDI regions. While females have a higher overall risk, the burden has grown more rapidly in males. These findings highlight the need for targeted interventions to address aging populations and reduce dementia risk factors.
This study aimed to investigate the associations between age, red blood cell distribution width (RDW), and short-term mortality in patients with traumatic brain injury (TBI), with a particular focus on the role of RDW in mediating the impact of age on mortality. We conducted a retrospective cohort analysis of 1,203 ICU-admitted TBI patients from the MIMIC-IV database (v3.1). Cox proportional hazards regression, restricted cubic splines (RCS), and mediation analysis were employed to evaluate the relationships between age, RDW, and mortality outcomes. Both advanced age (adjusted hazard ratio [HR] = 1.022 for 28-day mortality; HR adj = 1.031 for in-hospital mortality) and RDW (HR adj = 1.085 for 28-day mortality; HR adj = 1.094 for in-hospital mortality) were found to predict mortality (all P < 0.05) independently. RDW demonstrated a dose–response relationship with mortality: the highest quartile (Q4) exhibited a 2.061-fold increased risk of 28-day mortality ( P = 0.010) and a 2.086-fold increased risk of in-hospital mortality ( P = 0.022) compared to the lowest quartile (Q1). RCS analysis revealed significant nonlinear associations between age and 28-day mortality ( P < 0.05) and between RDW and in-hospital mortality ( P < 0.05). The mediation analysis demonstrated that RDW played a partial mediating role in age-related mortality, accounting for 4.40% of the total effect on 28-day mortality and 4.62% on in-hospital mortality (both P < 0.05). Deep learning survival models (e.g., Deepsurv: C-index: 0.759; IBS: 0.113; AUC (95% CI): 0.824 (0.735–0.900)) that incorporate age, RDW, and other clinical variables achieved robust predictive performance. Age and RDW are independent predictors of short-term mortality in TBI. RDW partially mediates the effect of age on TBI prognosis and shows potential as a practical biomarker for clinical risk stratification.
Background: Increasing evidence has linked inflammation to Hashimoto’s thyroiditis (HT) etiology. However, the causal role of circulating inflammatory proteins in HT remains uncertain. To investigate this, we conducted a bidirectional Mendelian randomization (MR) study. Methods: Genetic data for 91 inflammatory proteins and HT were sourced from publicly available GWAS databases. The PhenoScanner database was then searched for pleiotropic SNPs associated with potential confounders. Inverse variance weighted (IVW) analysis was used as the primary analysis, simultaneously supplemented by five sensitivity analyses to strengthen the results. Results: The results revealed that, after false discovery rate (FDR) correction, interleukin (IL)‐12p40 was causally associated with increased risk of HT (OR [95% CI] = 1.295 [1.172, 1.431], p = 3.66 × 10 −7 , PFDR = 3.33×10 −5 ). Conversely, none of the inflammatory proteins was a consequence of HT. Conclusion: This study suggests that IL‐12p40 is probably one of the factors correlated with HT etiology, contributing to a better understanding of the pathogenesis of HT and underscoring the potential for therapeutic interventions targeting inflammatory proteins.